Brain-derived neurotrophic factor reduces inflammation and hippocampal apoptosis in experimental Streptococcus pneumoniae meningitis
2017 · Journal of Neuroinflammation · 160 citations
https://doi.org/10.1186/s12974-017-0930-6
D
Danfeng Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
234
Papers
3.4K
Citations
31
h-index
83
i10-index
Danfeng Xu is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Prostate Cancer Diagnosis and Treatment & Renal cell carcinoma treatment. The author has an h-index of 31, co-authored 199 publications.
ORCID: 0000-0002-4175-1009Papers by this author
worksCell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells
2019 · EBioMedicine · 84 citations
https://doi.org/10.1016/j.ebiom.2019.03.032
IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway
2019 · Cell Death and Disease · 61 citations
https://doi.org/10.1038/s41419-019-1750-7
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling
2016 · Oncogene · 54 citations
https://doi.org/10.1038/onc.2016.307
Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis
2017 · The Aging Male · 50 citations
https://doi.org/10.1080/13685538.2017.1295436
Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma
2021 · Clinical and Translational Medicine · 26 citations
https://doi.org/10.1002/ctm2.328
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat